Search Constraints
« Previous |
1 - 10 of 15
|
Next »
Search Results
Select an image to start the slideshow
Siglec-15 is required for evasion of immune response in acute lymphoblastic leukemia
1 of 10
Strategies for engineering γδ T cells to treat pediatric cancers
2 of 10
MEK inhibition mediates immunomodulatory factors and cell populations in advanced biliary tract cancer
3 of 10
Understanding and Optimizing Gamma-Delta T cells as a Platform for Cellular Immunotherapies
4 of 10
Modulating Mitofusins to Enhance Therapeutic T Cell Expansion and Persistence
5 of 10
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12
6 of 10
An intratumoral immune niche sustains the anti-tumor immune response and supports the response to immunotherapy
7 of 10
Elucidating the Role of Soluble Galectin-9 in B-cell Acute Lymphoblastic Leukemia Pathogenesis
8 of 10
Evaluation of tumor membrane vesicle (TMV) vaccine immunotherapy in a HER2+ TUBO murine breast cancer model
9 of 10
Inhibiting VIP Receptor Signaling Promotes T Cell Mediated Immune Response in Murine Melanoma Models
10 of 10